Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sajida Hassan"'
Autor:
Ashraf N. Abdalla, Waleed H. Almalki, Imran Shahid, Sajida Hassan, Muhammad Ahmed, Ayman Khalid Johargy
Publikováno v:
Saudi Journal of Biological Sciences, Vol 28, Iss 1, Pp 1109-1122 (2021)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
Being the most conserved region of all hepatitis C virus (HCV) genotypes and sub-genotypes, the 5′ untranslated region (5′ UTR) of HCV genome signifies it’s importance as a potential target for anti-mRNA based treatment strategies like RNA inte
Autor:
Mariano J. Scian, Melissa Bowman, Michelle A. E. Anderson, Sajida Hassan, Sumitra Deb, Swati Palit Deb, Katherine E. R. Stagliano, Michael F. Miles
Publikováno v:
Molecular and Cellular Biology. 25:10097-10110
Mutation in the p53 tumor suppressor gene is a common event in human cancer (6, 36, 40, 43, 44, 65, 71, 72). Unlike what is seen for other tumor suppressors, in the majority of human carcinomas with p53 mutations, a protein with one amino acid substi
Autor:
Imran Shahid, Humera Kausar, Muhammad Kazim Khan, Sana Gull, Muhammad Sarwar, Waqar Ahmad, Sajida Hassan, Bushra Ijaz, Sultan Asad
Publikováno v:
Virology Journal, Vol 9, Iss 1, p 11 (2012)
Virology Journal
Virology Journal
Background Hepatitis C virus (HCV) is one of the major health concerns globally, with genotype 3a as the most prevalent in Pakistan. Lack of efficient HCV genotype 3a small animal models as well as genomic replicons has hampered the complete understa
Publikováno v:
Virology Journal
Virology Journal, Vol 8, Iss 1, p 221 (2011)
Virology Journal, Vol 8, Iss 1, p 221 (2011)
Background Hepatitis C virus (HCV) is a major causative agent of liver associated diseases leading to the development of hepatocellular carcinoma (HCC) all over the world and genotype-3a responsible for most of the cases in Pakistan. Due to the limit
Publikováno v:
Archives of virology. 156(3)
Hepatitis C virus (HCV) genotype 3a is considered a significant risk factor for the development of liver diseases and hepatocellular carcinoma for most of the cases in Pakistan. Because of the limited efficiency of the current therapy, RNA interferen
Autor:
Bushra Ijaz, Saba Khaliq, Muzna Zahur, Sajida Hassan, Muhammad Ansar, Shah Jahan, Sadaf A. Khaliq, Sheikh Riazuddin
Publikováno v:
Biotechnology advances. 28(1)
Hepatitis C virus is a major cause of liver associated diseases all over the world. Irrespective of the significant advances in the current therapy, drugs and vaccines are restricted with many factors such as toxicity, complexity, cost and resistance
Autor:
Bushra Ijaz, Shah Jahan, Mahwish Khan, Saba Khaliq, Baila Samreen, Waqar Ahmad, Sajida Hassan, Muhammad Hassan Siddique
Publikováno v:
Genetic Vaccines and Therapy
Background Hepatitis C virus (HCV) is a major health concern with almost 3% of the world's population (350 million individuals) and 10% of the Pakistani population chronically infected with this viral pathogen. The current therapy of interferon-α an